Hyundai Bioscience Co. Ltd (048410) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.018x

Based on the latest financial reports, Hyundai Bioscience Co. Ltd (048410) has a cash flow conversion efficiency ratio of -0.018x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.05 Billion ≈ $-1.39 Million USD) by net assets (₩111.98 Billion ≈ $75.89 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Hyundai Bioscience Co. Ltd (048410) liquidity interval to measure how many days the company can operate on defensive assets alone.

Hyundai Bioscience Co. Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Hyundai Bioscience Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Hyundai Bioscience Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hyundai Bioscience Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Anhui Wanyi Science and Technology Co Ltd SHG:688600	0.066x
TomTom NV AS:TOM2	0.065x
Ashot Ashkelon Industries Ltd TA:ASHO	0.030x
China Catalyst Holding Co. Ltd. A SHG:688267	0.047x
Recticel BR:RECT	0.082x
NOVA Technology Corporation Limited SHE:300921	N/A
Momentum Group AB (publ) ST:MMGR-B	0.046x
Jiangsu Yike Food Group Co.Ltd SHE:301116	0.228x

Annual Cash Flow Conversion Efficiency for Hyundai Bioscience Co. Ltd (2008–2025)

The table below shows the annual cash flow conversion efficiency of Hyundai Bioscience Co. Ltd from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see Hyundai Bioscience Co. Ltd stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩110.73 Billion ≈ $75.04 Million	₩-17.05 Billion ≈ $-11.55 Million	-0.154x	-369.06%
2024-12-31	₩39.44 Billion ≈ $26.73 Million	₩2.26 Billion ≈ $1.53 Million	0.057x	+143.12%
2023-12-31	₩45.27 Billion ≈ $30.68 Million	₩-6.01 Billion ≈ $-4.07 Million	-0.133x	+53.28%
2022-12-31	₩58.24 Billion ≈ $39.47 Million	₩-16.54 Billion ≈ $-11.21 Million	-0.284x	-3148.24%
2021-12-31	₩61.57 Billion ≈ $41.73 Million	₩-538.48 Million ≈ $-364.92K	-0.009x	-105.97%
2020-12-31	₩51.22 Billion ≈ $34.71 Million	₩7.50 Billion ≈ $5.08 Million	0.146x	-25.02%
2019-12-31	₩46.99 Billion ≈ $31.84 Million	₩9.18 Billion ≈ $6.22 Million	0.195x	+58.00%
2018-12-31	₩40.48 Billion ≈ $27.44 Million	₩5.01 Billion ≈ $3.39 Million	0.124x	+203.33%
2017-12-31	₩30.89 Billion ≈ $20.93 Million	₩-3.70 Billion ≈ $-2.50 Million	-0.120x	+49.76%
2016-12-31	₩18.21 Billion ≈ $12.34 Million	₩-4.34 Billion ≈ $-2.94 Million	-0.238x	-6808.19%
2015-12-31	₩24.60 Billion ≈ $16.67 Million	₩87.36 Million ≈ $59.20K	0.004x	-93.48%
2014-12-31	₩22.49 Billion ≈ $15.24 Million	₩1.22 Billion ≈ $829.60K	0.054x	-80.56%
2011-12-31	₩14.17 Billion ≈ $9.61 Million	₩3.97 Billion ≈ $2.69 Million	0.280x	+35.95%
2008-12-31	₩50.36 Billion ≈ $34.13 Million	₩10.37 Billion ≈ $7.03 Million	0.206x	--

About Hyundai Bioscience Co. Ltd

KQ:048410 Korea Biotechnology

Market Cap

$598.77 Million

₩883.56 Billion KRW

Market Cap Rank

#11468 Global

#314 in Korea

Share Price

₩9200.00

Change (1 day)

-5.15%

52-Week Range

₩4595.00 - ₩20000.00

All Time High

₩54700.00